ARTICLE | Clinical News
Thymosin alpha 1: Completed enrollment in its Phase III trial
May 3, 1993 7:00 AM UTC
Alpha 1 Biomedicals Inc. (ALBM) Product: Thymosin alpha 1 Indication: Chronic hepatitis B Status: Completed enrollment in its Phase III trial ...